# Biliary Obstruction

Biliary obstruction requires rapid separation of infected obstruction needing decompression from stable stone disease, benign stricture, and malignancy. Ultrasound establishes the initial anatomic assessment; MRCP, EUS, ERCP, tissue sampling, and multidisciplinary review then determine intervention.

**Clinical question:** How should physicians triage, image, and definitively manage suspected biliary obstruction?

Updated: 2026-09-16T00:43:53.434181+00:00

## What matters in practice
- Treat suspected acute cholangitis as infected biliary obstruction: initiate prompt evaluation and antibiotics, then arrange biliary drainage when obstruction is present or the patient is clinically severe or deteriorating. [1][16]
- Use transabdominal ultrasonography as the initial imaging study for suspected biliary obstruction; use MRCP or EUS to clarify ductal stones or strictures when immediate therapeutic ERCP is not required. [8][19][20]
- Do not use ERCP solely as a diagnostic substitute for cross-sectional ductal imaging in suspected PSC or indeterminate obstruction; reserve it for drainage or tissue acquisition when those actions will change management. [22]
- An obstructing distal or hilar lesion requires assessment for malignancy and benign mimics; cytology and histology are imperfect, so potentially curative surgery may be reasonable despite nondiagnostic sampling after multidisciplinary review. [3][5]
- In PSC, a suspicious dominant stricture requires noninvasive imaging review before high-risk endoscopic intervention when the patient is not septic; severe cholangitis requires urgent decompression. [6]

## Identify obstruction requiring urgent biliary drainage

The first branch is septic cholangitis versus stable obstructive disease.

Suspect acute cholangitis when systemic inflammation accompanies cholestasis and imaging evidence of obstruction, particularly in a patient with fever, jaundice, right-upper-quadrant pain, prior biliary instrumentation, known stones, or a biliary stricture. Charcot triad is present in only an estimated 50% to 70% of cases and should not be required before escalation. [1][4]

Escalate immediately to resuscitation, parenteral broad-spectrum antimicrobial therapy, blood cultures when feasible without delaying treatment, and urgent GI/interventional radiology consultation if hypotension, mental-status change, organ failure, or progressive clinical deterioration is present. Antibiotics address bacteremia but do not relieve the obstructed infected duct; biliary drainage is the critical source-control step. [1][11][16]

For cholangitis due to choledocholithiasis, favor endoscopic biliary drainage with ERCP when feasible. Delaying ERCP beyond 72 hours after presentation has been associated with greater vasopressor requirement, and each day of delay was associated with 1.44 additional hospital days in a prospective study. [2]
- Septic shock, organ dysfunction, or worsening sepsis despite antibiotics: prioritize urgent biliary decompression rather than additional diagnostic imaging. [1][2]
- Suspected biliary pancreatitis with cholangitis or persistent biliary obstruction: perform biliary sphincterotomy and endoscopic stone extraction within 72 hours of presentation. [2]
- When ERCP cannot achieve drainage, pursue an alternative drainage route with an experienced biliary intervention team rather than persist with ineffective medical therapy alone. [1][16]

*Initial disposition according to infection and obstruction status. [1][2][16]*

| Clinical branch | Immediate next action | What should not delay the action |
| --- | --- | --- |
| Cholangitis with shock, organ dysfunction, or altered mentation | Resuscitate, administer IV antibiotics, and arrange urgent biliary decompression. [1] | MRCP, EUS, or definitive stone characterization. [1][2] |
| Cholangitis without shock but with obstructed duct | Begin antibiotics and expedite therapeutic ERCP for drainage and obstruction management. [1][16] | Observation for antibiotic response alone when obstruction persists. [1] |
| Stable jaundice or cholestatic tests without infection | Perform ultrasound first, then use MRCP, EUS, or contrast cross-sectional imaging to define stone, stricture, or mass. [8][19][20][22] | Diagnostic ERCP unless drainage or tissue sampling is needed. [22] |

## Choose imaging that answers the next management question

Image for obstruction first, then select a test based on the suspected cause and need for intervention.

Order transabdominal ultrasonography as the first study for suspected biliary obstruction. It is the usual initial modality for suspected biliary disease and can identify ductal dilation, gallstones, and some obstructing masses; a nondiagnostic study should not end the evaluation when clinical or laboratory evidence of obstruction persists. [8][9][20]

In a stable patient with suspected choledocholithiasis after initial imaging, use MRCP or EUS to avoid diagnostic ERCP. EUS has reported pooled sensitivity of 94% and specificity of 95% for common-bile-duct stones, and its sensitivity is less affected by stones smaller than 5 mm than CT or MRCP. [19]

Use MRCP when a noninvasive map of the biliary tree is needed, especially for suspected stricture or PSC. In suspected PSC, MRI/MRCP has diagnostic accuracy comparable to ERCP, whereas ERCP carries serious complications and should be limited to therapeutic intervention or tissue sampling. If MRCP is equivocal or technically suboptimal in a patient with high pretest probability of PSC, repeat it at an experienced center using 3-dimensional reconstruction. [22]
- Visible ductal obstruction plus cholangitis: proceed to therapeutic ERCP rather than EUS or MRCP confirmation. [1][12]
- Negative CT or MRCP with ongoing suspicion for small common-bile-duct stones: use EUS, which can detect stones missed by cross-sectional imaging. [19]
- Painless jaundice or suspected hilar/distal malignant obstruction: obtain multiphasic contrast CT or MRI/MRCP to define anatomy and neoplastic invasion before determining drainage and tissue strategy. [22]

### Avoid diagnostic ERCP in stable obstruction

ERCP is a therapeutic and sampling procedure, not a default diagnostic test. In suspected PSC, it should be used when ductal intervention or brushings/cytology with fluorescence in situ hybridization are needed; MRI/MRCP is otherwise preferred for ductal assessment. [22]

*Imaging selection for stable suspected biliary obstruction. [8][19][20][22]*

| Clinical question | Preferred next test | Result that changes management |
| --- | --- | --- |
| Is there biliary dilation, gallstone disease, or an obvious mass? | Transabdominal ultrasound. [8][20] | Ductal dilation or a visible obstructive process supports escalation to duct-focused imaging or therapeutic intervention. [20] |
| Is occult choledocholithiasis present? | EUS or MRCP; favor EUS when small stones remain likely after negative cross-sectional imaging. [19] | Confirmed stone directs therapeutic ERCP rather than diagnostic ERCP. [19] |
| Is a stricture malignant, hilar, or PSC-related? | MRI/MRCP or multiphasic contrast CT; use ERCP for drainage or tissue acquisition when indicated. [22] | Defines level and extent of obstruction and guides sampling, drainage, and hepatobiliary multidisciplinary review. [22] |

## Manage choledocholithiasis by infection and persistence of obstruction

Stones are the leading cause of acute cholangitis and often require definitive duct clearance.

Choledocholithiasis is the most common cause of acute cholangitis. When it causes cholangitis, ERCP provides both source control and treatment through biliary drainage, sphincterotomy, and stone extraction as clinically appropriate. [11][16]

Do not perform ERCP merely to exclude stones in a stable patient. EUS can select patients for therapeutic ERCP and is particularly useful for small stones; reported sensitivity for stones smaller than 4 mm was higher for EUS than ERCP in the cited comparison. [19]

If acute gallstone pancreatitis is accompanied by cholangitis or persistent biliary obstruction, biliary sphincterotomy and endoscopic stone extraction should occur within 72 hours. Once it is safe to operate after gallstone pancreatitis, offer early laparoscopic cholecystectomy to reduce recurrent episodes. [2]
- Cholangitis from stones: drain the duct promptly; antibiotics alone do not provide adequate treatment for most patients with ongoing obstruction. [1]
- Stable suspected duct stone: confirm with EUS or MRCP before ERCP when the immediate need is diagnostic rather than drainage. [19]
- Post-pancreatitis recurrence prevention: offer early laparoscopic cholecystectomy when operative risk is acceptable. [2]

*Stone-related obstruction: intervention timing by clinical presentation. [1][2][19]*

| Presentation | Decision | Timing |
| --- | --- | --- |
| Acute cholangitis with suspected common-bile-duct stone | Therapeutic ERCP for drainage and stone-directed therapy. [1][16] | Urgent; do not wait for diagnostic confirmation when source control is needed. [1] |
| Gallstone pancreatitis with cholangitis or persistent obstruction | ERCP with sphincterotomy and stone extraction. [2] | Within 72 hours of presentation. [2] |
| Stable suspected choledocholithiasis | EUS or MRCP before therapeutic ERCP. [19] | Before ERCP when no urgent drainage indication exists. [19] |

## Evaluate biliary strictures for malignancy while preserving benign alternatives

A stricture requires an anatomic definition, a tissue strategy, and early hepatobiliary coordination.

For suspected perihilar or distal cholangiocarcinoma, obtain multiphasic contrast CT and/or MRI/MRCP to characterize the obstruction and assess neoplastic invasion. Obtain CA 19-9, but interpret it cautiously in the presence of biliary obstruction; obtain serum IgG4 when IgG4-related sclerosing cholangitis is a competing diagnosis. [22]

Use ERCP selectively to delineate anatomy when needed and to obtain brush cytology and fluorescence in situ hybridization in suspected perihilar or distal cholangiocarcinoma. A negative cytology result does not reliably exclude cancer: in PSC-associated cholangiocarcinoma assessment, biliary brushings had reported sensitivity of 43% and specificity of 97%. [6][22]

Review imaging, laboratory data, clinical history, and pathology in a hepatobiliary multidisciplinary setting. When potentially curative surgery is under consideration, histologic or cytologic confirmation is not absolute; after discussion with the patient, surgery may be appropriate despite nondiagnostic sampling if malignancy remains sufficiently likely and surgery can provide cure and diagnosis. [3][5]
- Consider benign stricture causes explicitly during multidisciplinary review, using clinical history and targeted serologic evaluation rather than assuming every obstructing stricture is malignant. [3][5]
- For distal malignant obstruction before planned surgery, do not drain solely because jaundice is present; preoperative drainage has been associated with increased postoperative complications. Consider drainage at bilirubin levels around 250 micromol/L or earlier for intractable pruritus, cholangitis, or organ dysfunction. [3]
- Painless jaundice should trigger cross-sectional imaging for perihilar or distal cholangiocarcinoma rather than empiric endoscopic treatment without staging information. [22]

### PSC-associated dominant strictures

In PSC with changing symptoms, biochemical deterioration, or signs of obstruction, obtain MRCP, dynamic liver MRI, and/or contrast CT and have the study reviewed by a hepatopancreatobiliary multidisciplinary team before high-risk endoscopic intervention when the patient is clinically stable. Severe acute cholangitis with a dominant stricture is the exception and requires urgent biliary decompression. [6]
- A negative or inadequate MRCP does not exclude PSC when pretest probability remains high; repeat high-quality MRI/MRCP at an experienced center. [22]
- Avoid chronic empiric rotation of antibiotics for recurrent cholangitis from complex intrahepatic PSC disease unless expert multidisciplinary and microbiology input supports it because resistance can develop. [6]

*Stricture evaluation: findings that direct the next step. [3][5][6][22]*

| Pattern | Key tests | Management implication |
| --- | --- | --- |
| Painless jaundice with hilar or distal obstruction | Multiphasic contrast CT and MRI/MRCP; CA 19-9 with obstruction-aware interpretation; serum IgG4. [22] | Assess malignant extent and benign mimics before drainage and sampling strategy. [22] |
| Indeterminate stricture with nondiagnostic brushings | ERCP brush cytology and FISH when indicated; multidisciplinary review of imaging and clinical context. [5][22] | Negative sampling does not exclude malignancy; consider surveillance versus potentially curative surgery through shared decision-making. [5] |
| PSC with dominant stricture and stable obstruction | MRCP, dynamic liver MRI, and/or contrast CT before invasive intervention. [6] | Use ERCP for a defined therapeutic or tissue-sampling objective. [6][22] |
| PSC dominant stricture with severe cholangitis | Urgent biliary decompression. [6] | Do not defer drainage for complete noninvasive characterization. [6] |

## Confirm durable drainage and complete cause-directed management

Clinical improvement after drainage does not replace etiologic evaluation.

After biliary decompression for cholangitis, reassess hemodynamics, mental status, organ dysfunction, fever trajectory, and cholestatic laboratory abnormalities. Failure to improve should prompt verification of drainage adequacy and reassessment for residual obstruction, complex hilar disease, or an alternative source of sepsis. Obstruction in multiple biliary branches is particularly relevant in hilar disease, where incomplete drainage increases procedural complexity and post-ERCP cholangitis risk. [1][13]

For stone disease, complete the recurrence-prevention plan after duct clearance; after gallstone pancreatitis, early laparoscopic cholecystectomy is the recommended preventive intervention when the patient can safely undergo surgery. [2]

For malignant or indeterminate obstruction, ensure prompt hepatobiliary multidisciplinary review after imaging and tissue acquisition. The decision between interval imaging and surgery when pathology is nondiagnostic should incorporate resectability, probability of malignancy, and the patient's priorities rather than relying on cytology alone. [5]
- Persistent sepsis after intervention: reassess for inadequate drainage or undrained segments. [1][13]
- Established or suspected malignant obstruction: coordinate imaging, pathology, and drainage decisions through a hepatobiliary multidisciplinary team. [3][5]
- Gallstone pancreatitis after stabilization: move from duct management to early cholecystectomy planning when safe. [2]

*Post-intervention checks that alter subsequent management. [1][2][5][13]*

| Finding after initial management | Interpretation | Next action |
| --- | --- | --- |
| Ongoing shock, fever, or organ dysfunction after drainage | Consider persistent infection, inadequate ductal drainage, or undrained biliary segments. [1][13] | Urgently reassess drainage adequacy and obstruction anatomy. [1] |
| Duct cleared after gallstone pancreatitis | Risk of recurrent biliary pancreatitis remains without gallbladder management. [2] | Offer early laparoscopic cholecystectomy when safe. [2] |
| Nondiagnostic tissue from suspected malignant stricture | Sampling limitations do not eliminate malignancy. [5][6] | Use multidisciplinary review to choose follow-up imaging versus surgery for definitive diagnosis. [5] |

## References
1. Acute cholangitis - Symptoms, diagnosis and treatment | BMJ Best Practice — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-gb/3000149?q=Acute+cholangitis&c=suggested
2. Updated guideline on the management of common bile ... — gut.bmj.com — https://gut.bmj.com/content/66/5/765
3. British Society of Gastroenterology guidelines for the diagnosis ... - Gut — gut.bmj.com — https://gut.bmj.com/content/gutjnl/73/1/16.full.pdf
4. Acute cholangitis - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/345?locale=zh_CN
5. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma | Gut — gut.bmj.com — https://gut.bmj.com/content/73/1/16
6. British Society of Gastroenterology and UK-PSC guidelines for ... - Gut — gut.bmj.com — https://gut.bmj.com/content/gutjnl/68/8/1356.full.pdf
7. Treatment of Acute Biliary Pancreatitis — www.nejm.org — https://www.nejm.org/doi/abs/10.1056/NEJM199701233360409
8. Imaging in biliary obstruction Commentary — www.bmj.com — https://www.bmj.com/content/329/7464/501.1.full.pdf
9. Imaging in biliary obstruction — www.bmj.com — https://www.bmj.com/content/329/7464/501.1
10. induced pancreatitis: a systematic review of the literature | BMJ Open — bmjopen.bmj.com — https://bmjopen.bmj.com/content/bmjopen/9/11/e027451.full.pdf
11. Diagnosis and management of acute cholangitis | Nature Reviews Gastroenterology & Hepatology — www.nature.com — https://www.nature.com/articles/nrgastro.2009.126
12. Machine learning prediction of common bile duct stones using synthetic data to guide emergency ERCP decisions | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-026-45014-1
13. Risk prediction of cholangitis after stent implantation based on machine learning | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-024-64734-w
14. Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-018-28309-w
15. ACUTE (ASCENDING) CHOLANGITIS - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0891552005701197
16. Prospective Assessment of Clinical Criteria for Diagnosis and Severity of Acute Cholangitis — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2590030723000156
17. Verification of the Tokyo guidelines for acute cholangitis secondary to benign and malignant biliary obstruction: experience from a Chinese tertiary hospital - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1499387213600624
18. Prospective Assessment of Clinical Criteria for Diagnosis and Severity of Acute Cholangitis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S2590030723000156
19. The efficacy of endoscopic ultrasound for the... : Journal of the Chinese Medical Association — journals.lww.com — https://journals.lww.com/jcma/fulltext/2012/07000/the_efficacy_of_endoscopic_ultrasound_for_the.1.aspx
20. Biliary strictures: diagnostic considerations and approach — academic.oup.com — https://academic.oup.com/gastro/article/3/1/22/589183
21. Neonatal cholestasis: Timely triumph : Clinical Liver Disease — journals.lww.com — https://journals.lww.com/cld/fulltext/10.1097/cld.0000000000000135~neonatal-cholestasis-timely-triumph
22. AASLD practice guidance on primary sclerosing... : Hepatology — journals.lww.com — https://journals.lww.com/hep/pdf/10.1002/hep.32771~aasld-practice-guidance-on-primary-sclerosing-cholangitis
23. Endoscopic retrograde cholangiopancreatography quality ... — academic.oup.com — https://academic.oup.com/jcag/advance-article-pdf/doi/10.1093/jcag/gwag034/70998990/gwag034.pdf
24. Diagnosis and management of acute cholangitis - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/19652653

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.